DE68927462D1 - Aus serum isolierte und das immunsystem beeinflussende polypeptide und deren verwendung - Google Patents

Aus serum isolierte und das immunsystem beeinflussende polypeptide und deren verwendung

Info

Publication number
DE68927462D1
DE68927462D1 DE68927462T DE68927462T DE68927462D1 DE 68927462 D1 DE68927462 D1 DE 68927462D1 DE 68927462 T DE68927462 T DE 68927462T DE 68927462 T DE68927462 T DE 68927462T DE 68927462 D1 DE68927462 D1 DE 68927462D1
Authority
DE
Germany
Prior art keywords
sips
serum
influencing
immune system
polypeptides isolated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68927462T
Other languages
English (en)
Other versions
DE68927462T2 (de
Inventor
Yi-Han Chang
Edward Abraham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
University of California Berkeley
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, University of California Berkeley filed Critical University of California
Application granted granted Critical
Publication of DE68927462D1 publication Critical patent/DE68927462D1/de
Publication of DE68927462T2 publication Critical patent/DE68927462T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE68927462T 1988-09-09 1989-09-05 Aus serum isolierte und das immunsystem beeinflussende polypeptide und deren verwendung Expired - Fee Related DE68927462T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24273988A 1988-09-09 1988-09-09
PCT/US1989/003800 WO1990002760A1 (en) 1988-09-09 1989-09-05 Serum immunoregulatory polypeptide and uses therefor

Publications (2)

Publication Number Publication Date
DE68927462D1 true DE68927462D1 (de) 1996-12-19
DE68927462T2 DE68927462T2 (de) 1997-06-05

Family

ID=22915997

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68927462T Expired - Fee Related DE68927462T2 (de) 1988-09-09 1989-09-05 Aus serum isolierte und das immunsystem beeinflussende polypeptide und deren verwendung

Country Status (7)

Country Link
EP (1) EP0434744B1 (de)
JP (1) JPH04501258A (de)
AT (1) ATE145215T1 (de)
AU (1) AU4304289A (de)
CA (1) CA1339868C (de)
DE (1) DE68927462T2 (de)
WO (1) WO1990002760A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650487A (en) * 1988-09-09 1997-07-22 The Regents Of The University Of California Serum immunoregulatory polypeptides and uses therefor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0741072B2 (ja) * 1986-01-14 1995-05-10 鐘淵化学工業株式会社 免疫機能調節器

Also Published As

Publication number Publication date
CA1339868C (en) 1998-05-12
EP0434744B1 (de) 1996-11-13
ATE145215T1 (de) 1996-11-15
AU4304289A (en) 1990-04-02
JPH04501258A (ja) 1992-03-05
EP0434744A4 (en) 1991-10-16
DE68927462T2 (de) 1997-06-05
EP0434744A1 (de) 1991-07-03
WO1990002760A1 (en) 1990-03-22

Similar Documents

Publication Publication Date Title
Fibach et al. Induction of colony formation in vitro by human lymphocytes
NO872988L (no) Pattedyr-interleukin-4.
FI90983C (fi) Menetelmä yhdistelmäinterferonipolypeptidien valmistamiseksi
AU2404688A (en) Polypeptides
IL136621A0 (en) Cell surface glycoproteins associated with human b cell lymphomas
AU7197087A (en) Homogeneous human interleukin 2 and process therefor
ATE84798T1 (de) Transformierender wachstumsfaktor-beta.
BG96316A (bg) Метод за изолиране на фактор viii
Cormann et al. Isolation of follicular dendritic cells from human tonsils and adenoids. V. Effect on lymphocyte proliferation and differentiation
ATE145215T1 (de) Aus serum isolierte und das immunsystem beeinflussende polypeptide und deren verwendung
Halpern Human nonspecific suppressive lymphokines
FI56317C (fi) Foerfarande foer isolering av tymosin alfa1 med immunitetpotentierande verkan
ATE137241T1 (de) Oligosaccharides
Acuto et al. An efficient method for purification of human T-cell growth factor
Beckman et al. Gc subtypes in Finns, Swedes and Swedish Lapps
AU590717B2 (en) Genetically engineered bovine interferon of the IFN-a-type
CA1193215A (en) Interleukin and its analogous immune regulating factors
GR3006212T3 (de)
KANNO et al. A macrophage differentiating factor derived from human T cell line HUT102 acting on a mouse myeloid cell line M1
Butz et al. CHARACTERIZATION OF TWO STRUCTURALLY RELATED PROTEOCHONDROITINSULFATES FROM A HUMAN B LYMPHOBLASTOID CELL LINE
Oppenheim et al. Bi-directional macrophage-lymphocyte interactions modulate immune responses
Munakata et al. Isolation and characterization of a high-molecular-weight glycoprotein from the endometrium of porcine uteri
JPS6219533A (ja) インタ−ロイキン２レセプタ−発現誘導物質ｂ
EP1175910A3 (de) Methoden und Verbindungen zur Verhinderung der Transplantat-Abstossung
SU1494274A1 (ru) Способ получения фактора, ингибирующего миграционную активность макрофагов и лейкоцитов

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, OAKLA

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee